Results 71 to 80 of about 3,485 (208)

Neuroprotective Effects of Etidronate and 2,3,3-Trisphosphonate Against Glutamate-Induced Toxicity in PC12 Cells [PDF]

open access: yes, 2016
Etidronate is one of the best known bisphosphonates (BP) derivatives. It is often used as a reference drug in research related to hypercalcaemia and other common bone diseases.
Yang, Zhuo   +4 more
core   +1 more source

The Effect of Different Compositions and Concentrations of Etidronate-Containing Irrigants on the Antibacterial Activity of Sodium Hypochlorite against Enterococcus faecalis and Candida albicans

open access: yesDentistry Journal
We assessed the effect of different compositions and concentrations of two etidronate-containing irrigants on the antibacterial activity of sodium hypochlorite (SH) against Enterococcus faecalis and Candida albicans in vitro. Pure cultures of C. albicans
Nina Novozhilova   +7 more
doaj   +1 more source

Literature Review of Using Bisphosphonates in the Treatment of Calciphylaxis

open access: yes罕见病研究
Objective To analyze the effectiveness and safety of bisphosphonates in the treatment of patients with calcification defense. Methods PubMed, Embase databases, CNKI and Wanfang were searched to collect the case reports and clinical studies of ...
LIANG Chunsu   +6 more
doaj   +1 more source

Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis

open access: yesCase Reports in Rheumatology, 2015
A 17-year-old boy with juvenile dermatomyositis presented with typical skin symptoms, mild myositis, and bilateral lower limb calcinosis. His skin and muscle symptoms responded to treatment with prednisolone and azathioprine.
Takayuki Wakabayashi   +3 more
doaj   +1 more source

Further hearing loss during osteoporosis treatment with etidronate

open access: yes, 1998
Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for ...
Yesil, S   +5 more
core   +1 more source

“Greener” synthesis of bisphosphonic/dronic acid derivatives

open access: yesGreen Processing and Synthesis, 2014
According to literature, the synthesis of dronic acid derivatives from the corresponding carboxylic acids using phosphorus trichloride and phosphorous acid as the P-reactants is controversial, due to the wide range of molar ratios and diverse conditions.
Kovács Rita   +4 more
doaj   +1 more source

Treatment of Paget Disease of Bone (Osteitis Deformans): Results of a One-Year Study With Sodium Etidronate

open access: yes, 1974
A double-blind crossover study was performed in which 50 symptomatic patients with Paget disease were treated with sodium etidronate (EHDP) doses of 1, 2.5, 5, 10, or 20 mg/kg or were given placebo.
Altman, Roy D   +5 more
core   +1 more source

Organic tissue dissolution in clodronate and etidronate mixtures with sodium hypochlorite

open access: yes, 2019
Mixtures of clodronate with sodium hypochlorite (NaOCl) better maintain free available chlorine (FAC) than etidronate-hypochlorite mixtures. This research aimed to compare organic tissue dissolution and residual FAC between clodronate and etidronate ...
Scott, Suzanne   +3 more
core   +1 more source

The inhibition effect of etidronate on degradation behavior of Mg–Zn–Y-Nd-Zr alloy

open access: yesSmart Materials in Manufacturing
The control of corrosion behavior of Mg alloys for biomedical applications is a research hotspot in the field of biodegradable metallic implant materials. In recent years, the employment of corrosion inhibitors for regulating the corrosion behavior of Mg
Di Mei   +5 more
doaj   +1 more source

Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone

open access: yes, 1997
Paget's disease of bone is characterized by a high bone turnover. Therefore, antiresorbing agents such as bisphosphonates are clearly indicated.
J. Malghem   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy